Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to Oral Agents in Diabetes (ROAD) Pilot Study
2008-004790-18Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin, sitagliptin, pioglitazone and gliclazide in type 2 diabetes mellitus (T2DM), sponsored by University of Dundee. Primary endpoint: HbA1c reduction at 6 months. Started Sep 2008; status: terminated.
02
Drugs
metforminsitagliptinpioglitazonegliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-004790-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004790-18.